Nanobiotix SA
NBTXHealthcare|Biotechnology|France
$39.95
+1.12 (+2.88%)
Upcoming Data Readouts (2)
Apr 2027
Est. completion
P1Radiotherapy
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
NCT03589339n=145
Aug 2028
Est. completion
P1P2Locally-Advanced Non-Small Cell Lung Cancer
NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer
NCT07224152n=40